Fuji Pharma Co., Ltd. 4554.T

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-09-30

Average Intrinsic Value
$422.87M
Market Cap
$286.78M
Margin of Safety
32.2%
Intrinsic / Market Ratio
1.47

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

573.41M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

373.56M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

321.64M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

422.87M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

422.87M USD

from the sum above

Market Cap

286.78M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

1.47×

the ratio the screener ranks by; Margin of Safety +32.2% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 573.41M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)584.10M USD
−②Net Debt Today117.29M USD
+③Growth Value106.60M USD
=Value573.41M USD

EPV of the Operations (NOPAT over WACC)

584.10M USD

Net debt today

-117.29M USD

Growth Value

+106.60M USD

Value

573.41M USD

①EPV (earnings power value)

584.10M USD

②Net Debt Today

117.29M USD

③Growth Value

106.60M USD

Market value

Market Cap286.78M USD

Today's price times the shares.

Value vs market

Margin of Safety+50.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 373.56M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE158.25M USD
+②Equity at Year 15, Today215.31M USD
=Value373.56M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

158.25M USD

②Equity at Year 15, Today

215.31M USD

Market value

Market Cap286.78M USD

Today's price times the shares.

Value vs market

Margin of Safety+23.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 321.64M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 321.64M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap286.78M USD

Today's price times the shares.

Value vs market

Margin of Safety+10.8%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 4.27%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.32×Market Risk Premium 6.00%= 6.44%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 6.74M USDPretax Income 26.95M USD= 25.00%

The tax the interest saves.

Interest Expense =EBIT 29.17M USD−Pretax Income 26.95M USD= 2.22M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 2.22M USDTotal Debt 185.47M USD×(1 − Tax Rate for WACC 25.00%)= 0.90%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 185.47M USDMarket Cap + Total Debt 286.78M USD + 185.47M USD= 39.27%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 60.73%×Cost of Equity 6.44%+Debt Weight 39.27%×Cost of Debt 0.90%= 4.27%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 613.33M USD − Total Liabilities 291.69M USD = Book Value Today 321.64M USD

Total Debt 185.47M USD − Cash and Short-Term Investments 68.18M USD = Net Debt Today 117.29M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 17.5%at most 5%does not pass26,119,761 / 24,302,808
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets3.1%at least -10.0%passes(39.08M USD − 20.21M USD) ÷ 613.33M USD
Price to bookMarket Cap ÷ Book Value Today0.89×at most 3×passes286.78M USD ÷ 321.64M USD
Operating marginOperating Income ÷ Revenue9.7%above 10.0%does not pass33.64M USD ÷ 348.12M USD
Revenue growthRevenue ÷ Revenue a Year Before − 17.6%above 10.0%does not pass348.12M USD / 323.46M USD
Net cash(Cash − Total Debt) ÷ Market Cap-40.9%above -30%does not pass(68.18M USD − 185.47M USD) ÷ 286.78M USD
Operating efficiencyOperating Income ÷ Gross Profit24.1%above 25.0%does not pass33.64M USD ÷ 139.87M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

1.72K USD

Enterprise value

63.94B USD

market cap plus net debt

EV / EBITDA

5.70×

Price / book

0.87×

the provider's book

Price / earnings

17.41×

Return on equity

6.1%

the provider's, not the engine's

Profit margin

5.0%

Revenue growth

21.8%

Analyst target, mean

2.95K USD

Analysts

2

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

245.53M274.08M323.46M348.12M

Gross profit

100.90M110.69M125.10M139.87M

Operating income

26.20M25.89M27.22M33.64M

EBITDA

operating income before depreciation and amortisation

45.36M50.47M85.19M55.88M

Pretax income

25.80M29.49M58.02M26.95M

Net income

18.69M23.02M43.09M20.21M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

20.13M21.75M19.80M23.93M

R&D

17.22M21.34M23.84M22.53M
Balance sheet, year end

Total assets

523.53M571.98M630.96M629.22M

Total liabilities

275.39M295.99M311.55M313.24M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

248.12M275.97M319.39M315.95M

Total debt

170.28M194.04M205.09M208.40M

Cash and equivalents

24.58M15.58M32.14M48.81M

Net PP&E

fixed assets after depreciation

130.03M137.73M146.60M140.89M

Working capital

current assets less current liabilities

74.52M62.63M46.77M114.01M
Cash flow

Operating cash flow

-4.56M12.85M29.10M39.08M

Capital expenditure

paid out, so below zero

-86.10M-26.12M-30.65M-25.96M

Depreciation and amortisation

19.02M20.26M25.80M26.71M

Free cash flow

operating cash flow plus capital expenditure

-90.66M-13.27M-1.55M13.12M